Clinical Trial: Acupuncture as a Supplemental Treatment for Bipolar Depression


	Home	\|	Search	\|	Browse	\|	Resources	\|	Help	\|	What's New	\|	About

Acupuncture as a Supplemental Treatment for Bipolar Depression

This study has been completed.

Sponsored by:	National Institute of Mental Health (NIMH)
Information provided by:	National Institute of Mental Health (NIMH)

Purpose

The purpose of this study is to evaluate the effectiveness of acupuncture in the treatment of Bipolar Depression.

Condition	Treatment or Intervention	Phase
Bipolar Disorder	Procedure: Acupuncture	Phase II

MedlinePlus related topics: Bipolar Disorder

Study Type: Interventional
Study Design: Treatment, Randomized, Single Blind, Active Control, Parallel Assignment, Safety/Efficacy Study

Official Title: Adjunctive Acupuncture as a Treatment for Bipolar Depression

Further Study Details:

Expected Total Enrollment: 30

Study start: November 2001

Patients receive 8 weeks (12 sessions) of acupuncture treatment plus stable medication. Patients are randomly assigned to receive either acupuncture designed to relieve symptoms of depression or acupuncture designed to relieve some other legitimate physical condition. A comparison group of patients who take medication but do not receive acupuncture is assessed to evaluate the effectiveness of medication alone. Patients participate in clinical assessment each week, which includes visiting with a psychiatrist and completing symptom rating scales.

Eligibility

Ages Eligible for Study: 18 Years - 60 Years, Genders Eligible for Study: Both

Criteria

Inclusion Criteria:

Meet DSM-IV criteria for bipolar I disorder or bipolar II disorder
Demonstrate symptoms of depression as determined by a minimum score of 25 on the Inventory for Depressive Symptoms-Clinican Rated Scale
Have taken stable psychoactive medications for at least 30 days prior to study entry

Location Information

Texas
Bipolar Disorder Clinic and Research Program, Dallas, Texas, 75390, United States

More Information

Study ID Numbers: NIMH-61589-01A1
Record last reviewed: September 2004
Record first received: October 29, 2003
ClinicalTrials.gov Identifier: NCT00071669
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2004-10-20

U.S. National Library of Medicine, Contact NLM Customer Service

National Institutes of Health, Department of Health & Human Services